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Abstract
Purpose—We examine the relationship between urine and stone cultures in a large cohort of 
patients undergoing percutaneous stone removal and compare the findings in infectious vs 
metabolic calculi.
Materials and Methods—A total of 776 patients treated with percutaneous nephrolithotomy 
who had preoperative urine cultures and intraoperative stone cultures were included in the study. 
Statistical analysis used chi-square or logistic fit analysis as appropriate.
Results—Preoperative urine culture was positive in 352 patients (45.4%) and stone cultures were 
positive in 300 patients (38.7%). There were 75 patients (9.7%) with negative preoperative 
cultures who had positive stone cultures, and in patients with both cultures positive the organisms 
differed in 103 (13.3%). Gram-positive organisms predominated in preoperative urine and stone 
cultures.
Conclusions—Preoperative urine cultures in patients undergoing percutaneous nephrolithotomy 
are unreliable as there is a discordance with intraoperative stone cultures in almost a quarter of 
cases. There has been a notable shift toward gram-positive organisms in this cohort of patients.
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Renal calculi requiring percutaneous nephrolithotomy commonly harbor infectious 
organisms even when the stone is metabolic in origin.1–3 Furthermore, a sterile voided urine 
does not preclude the presence of pathogens in the stone4,5 or the development of 
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postoperative bacteriuria.6 Several recent studies have found that the risk of infectious 
complications after PCNL correlate better with stone cultures than preoperative voided or 
renal pelvic cultures.7–9 These studies further noted a poor correlation between voided and 
stone cultures but are limited by small patient numbers.7–10 Although these groups have 
recommended the routine collection of stone cultures during PCNL, this is not standard 
practice for most urologists and the AUA (American Urological Association) guidelines 
make no recommendations in this regard.4 The European Association of Urology guidelines 
on urolithiasis state that intraoperative renal stone culture may help to select postoperative 
antibiotics.11
In this study we determine the ability of preoperative urine cultures to predict the presence 
of infection in kidney stones and identify the organism(s) present in the stone. Stone 
composition is analyzed in relation to urine and stone culture findings. We report a shift 
toward a predominance of gram-positive organisms associated with this complex cohort of 
patients requiring PCNL. Finally, we present our data regarding sepsis after PCNL, which is 
among the most significant complications after this procedure. To our knowledge this study 
represents the largest series of patients undergoing PCNL reported to date evaluating the 
correlation between preoperative urine culture and stone culture.
METHODS
An institutional review board approved prospectively collected database (IRB#101002243) 
has been maintained at our institution since April 1999 for all PCNL procedures. Informed 
consent was obtained from all patients entered in the database. We retrospectively identified 
1,295 consecutive patients who underwent PCNL for renal stones at our institution between 
April 1999 and January 2014. Patients who met the study inclusion criteria had results for 
preoperative urine culture and intraoperative stone culture.
At our institution a preoperative bladder urine culture is obtained from all patients scheduled 
to undergo PCNL. All preliminary urine cultures reported as contaminated are requested to 
be fully speciated by the microbiology laboratory. Patients with a positive urine culture or a 
history of urosepsis or recurrent urinary tract infections are treated before PCNL for at least 
2 weeks with culture specific antibiotics. Those with a negative urine culture are routinely 
treated for 1 week with oral antibiotics (usually a fluoroquinolone unless contraindicated by 
patient allergy). All patients receive a prophylactic antibiotic intravenously before the start 
of surgery.
At our institution PCNL is a single stage procedure. Initially a ureteral catheter is placed. 
With the patient in the prone position, access is established by the treating urologist under 
fluoroscopic guidance. The nephrostomy tract is balloon dilated and a 30Fr Amplatz sheath 
is placed in all instances. Stone material is fragmented using a combination of ultrasonic and 
pneumatic lithotripsy as indicated. Sterile graspers are used to retrieve stone fragments, 
which are immediately transferred to a sterile collection cup containing sterile saline. Care is 
taken with the stone to avoid skin contaminants. The stone fragments are crushed into 
powder using a sterile needle driver. The specimen is then sent for culture and sensitivity.
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Flexible nephroscopy is performed in all cases. A nephrostomy tube, usually a 10Fr Cope 
loop (Cook Urological, Bloomington, Indiana) is placed at the conclusion of the PCNL 
procedure in all cases. Noncontrast CT is performed on postoperative day 1. If CT shows no 
residual stones, a nephrostogram is obtained. If adequate drainage is confirmed, the 
nephrostomy tube is removed and the patient is discharged from the hospital. If drainage is 
poor or absent, the patient is discharged home with the nephrostomy tube and scheduled for 
a repeat nephrostogram a few days later. When remaining stone fragments are identified on 
CT, second look nephroscopy is performed on postoperative day 2. Patients can generally be 
discharged home after the secondary procedure. Antibiotics are continued in the 
postoperative period for at least 1 week. If the results of the stone culture are positive, 
antibiotics are adjusted based on sensitivities and continued for 3 months after surgery.
In situations where a culture grew multiple organisms with only one being a urease 
producing organism, that case was grouped in the category of urea splitting organisms.12 
When a culture grew multiple organisms without a urease producing organism or had more 
than 1 urease producing organism, that case was grouped in multiple organisms. Multiple 
organisms were cultured in 6% of preoperative urine cultures and 8.3% of stone cultures (see 
figure). The identity of organisms cultured was missing for 1 patient in each of the 
preoperative urine culture and stone culture groups. Statistical analysis used chi-square or 
logistic fit analyses as appropriate. Calculations were done using JMP® software.
RESULTS
Of 1,295 consecutive patients 828 had results for intraoperative stone culture. Among these 
patients 776 also had results for preoperative urine culture and were included in the final 
analysis. Patient and stone demographics are summarized in table 1. Overall 352 (45.4%) 
patients had a positive preoperative urine culture while 300 (38.7%) had a positive stone 
culture. The figure illustrates the type and number/percentage of organisms identified in 
bladder urine (part A) and kidney stones (part B). Staphylococcus was the most common 
organism cultured from preoperative urine cultures (22.2%) and kidney stones (25.3%). 
Other common organisms found on preoperative urine culture were proteus species (15.3%), 
Escherichia coli (13.1%) and enterococcus (8.8%). Other common stone culture pathogens 
were enterococcus (13.7%), followed by proteus (13%) and candida (12.7%).
Both cultures were negative in 349 (45%) patients. Overall 127 (16.4%) patients with 
positive preoperative urine cultures had negative stone cultures. On the other hand, a positive 
stone culture in the presence of sterile urine was identified in 75 (9.7%) patients. There were 
225 (29%) cases with positive preoperative urine and stone cultures. The same organisms 
were identified in both cultures in 122 (54.2%) patients. However, different organisms were 
isolated between cultures in 103 (45.8%) patients, 13.3% overall. For this analysis the 
cultures were considered discordant if any pathogen was cultured in the stone that was not 
cultured in the urine. Based on these data, preoperative urine culture was able to predict the 
correct organism(s) in kidney stones with 62% sensitivity, 60% specificity and a positive 
predictive value of only 35% (table 2).
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Sepsis developed in 13 (1.7%) patients in the postoperative period (table 3). Of the 13 
patients 9 had discordance between urine and stone culture. In 1 patient the same organism 
grew in both cultures, 1 had a positive urine culture and a negative stone culture, and 2 had 
both cultures negative. Of the patients with sepsis 11 had blood cultures obtained, of which 4 
were positive. Blood and stone cultures were concordant in 2 patients while none of the 
blood and urine cultures agreed. Only 1 patient experiencing sepsis had stones composed of 
struvite and, in this case, both cultures were positive for a proteus organism. The remaining 
12 patients in whom sepsis developed after PCNL had metabolic stones.
We further analyzed our urine and stone culture data with respect to stone composition. 
Patients were separated into a group with metabolic stones and a group whose stones 
contained mixtures of struvite and/or highly carbonated apatite (table 4). Among patients 
with metabolic stones 39.1% (252 of 645) had a positive urine culture and 32.7% (211 of 
645) had a positive stone culture. Among patients with stones containing struvite and/or 
carbonate apatite, urine and stone cultures were positive in 79.2% (99 of 125) and in 69.6% 
(87 of 125), respectively. Thus, the likelihood of a positive urine or stone culture was 
considerably greater in patients having struvite and/or carbonate apatite stones (p <0.0001). 
However, 12% of patients with struvite and/or carbonate apatite stones were found to have 
negative urine and stone cultures. Stone analysis was not performed in 6 patients.
A subgroup analysis of struvite and/or carbonate apatite stone formers with positive stone 
cultures was performed. Urease producing organisms were isolated in 75.9% (66 of 87) of 
patients and nonurease producing organisms were cultured in 23% (20 of 87). The identity 
of the organism(s) cultured was missing for 1 patient. Overall a negative stone culture or 
nonurease producing organism was found in 42.4% (53 of 125) of patients with struvite 
and/or carbonate apatite calculi.
DISCUSSION
There are 2 broad themes suggested by these data. This large cohort confirms the findings of 
earlier, smaller series that preoperative urine culture is an unreliable predictor of the 
presence of a positive stone culture. In our data 9.7% of cases had a positive stone culture in 
the face of a negative preoperative urine culture. Furthermore, discordance between 
preoperative urine culture and stone culture was common (13.3% of cases), meaning that 
almost a quarter of the patients in this series undergoing PCNL had organisms identified on 
stone culture that were not apparent from preoperative urine cultures.
The improper identification of urinary pathogens may result in devastating consequences for 
patients in whom sepsis develops in the postoperative period. Among the patients with sepsis 
in this study 9 of 13 (69.2%) had discordance between urine and stone cultures. Although 
the reported rates of sepsis after PCNL are relatively low, the treatment of severe sepsis with 
inappropriate antimicrobial coverage may lead to significant morbidity and mortality as well 
as increased health care expenditures. The American Urological Association Best Practice 
Policy Statement on Urological Surgery Antimicrobial Prophylaxis makes recommendations 
regarding perioperative antibiotics for PCNL.13 The 2007 Guideline for the Management of 
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Ureteral Calculi recommends obtaining a urine culture and treating bacteriuria before 
intervention.14 However, stone culture is not mentioned in either of these publications.
Reports of the occurrence of sepsis after PCNL in the literature range from 0.9% to 4.7%.15 
The differences among studies are likely related to highly variable definitions and methods 
of data collection.15 Often studies addressing the usefulness of stone cultures report the 
incidence of SIRS after PCNL.7–9 However, SIRS criteria are nonspecific, and may be 
attributed to any number of etiologies in the postoperative period, including major surgical 
procedures, cardiogenic events, atelectasis, hypovolemia and pain.16 Therefore, we chose to 
analyze our data based on the occurrence of septic events which require the presence of a 
documented infection in addition to SIRS. Our hospital has a tertiary referral practice 
specializing in complex stones. Such a patient base would presumably increase the number 
of infectious stones, but nevertheless the sepsis rate in this study was low (1.7%). We 
attribute much of this to our practice pattern regarding the administration of preoperative, 
perioperative and postoperative antibiotics, the routine collection of stone cultures, 
consistent use of flexible nephroscopy to remove fragments and an emphasis on achieving 
stone-free status through secondary procedures. Resistant organisms and Clostridium 
difficile infections have not been an issue in our experience, which is consistent with the 
recent publication from the Mayo Clinic Rochester, where similar perioperative antibiotic 
protocols are used.17
In addition, it is clear that the microbiology of stone disease has changed dramatically 
during the last generation from predominantly gram-negative to now predominantly gram-
positive organisms.18–21 There are a number of possible explanations. Several groups have 
documented the decreasing frequency of struvite stones in the adult and pediatric/neurogenic 
patient population.21,22 In this series proteus and morganella species were identified in only 
13.7% (41 of 300) of positive stone cultures and 17.2% (61 of 354) of positive preoperative 
urine cultures. Clearly the major advances in the urological care of patients with structural 
and neurogenic disorders have had an impact on reducing stones resulting from ureolysis.
The dramatic developments in the minimally invasive treatment of stone disease (ureteral 
stenting, extracorporeal shock wave lithotripsy, ureteroscopy, PCNL) may also be a factor in 
the microbiology of stone disease. Open surgical lithotomy has been relegated to historical 
status and has been supplanted by approaches using a much larger number of minimally 
invasive procedures. These entail repeated episodes of instrumentation of the urinary tract, 
providing opportunities for the introduction of gram-positive organisms.
The finding of candida in 12% of stone cultures deserves comment for several reasons. Our 
tertiary referral practice accrues many patients with complex stones requiring percutaneous 
stone removal who have neurogenic bladders, indwelling catheters of some sort, urinary 
diversion or who have undergone instrumentation on multiple occasions. These patients have 
typically received multiple courses of antibiotics before they reach us and, as a group, are at 
high risk for candida infections. Indeed, 1 of 4 patients with positive blood cultures had 
candida species grow. For this reason, patients with the previously mentioned risk factors are 
treated preoperatively with antifungal agents.
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Also noteworthy is the finding of enterococcus in 13.7% (41 of 300) of patients with a 
positive stone culture as this organism is not covered by cephalosporins and is often resistant 
to fluoroquinolones. AUA guidelines permit the use of cephalosporins as routine prophylaxis 
before PCNL. Informing this concern is the observation that 2 of 4 cases with sepsis and 
positive blood cultures grew enterococcus.
Many staghorn stones contain struvite (magnesium ammonium phosphate) and/or carbonate 
apatite.4 Stones of this composition are associated with microorganisms that produce urease, 
an enzyme that catalyzes the hydrolysis of urea into ammonia and hydrogen ions.4,5 Stone 
mineral composition has been proposed as a marker for the presence of infectious organisms 
in a stone. However, Englert et al showed that among positive stone cultures, urease 
producing organisms were cultured in 71% of cases with no difference observed among 
stones of different compositions.23 They concluded that mineral content is an imperfect 
indicator of the presence of infectious organisms in kidney stones, an observation consistent 
with the data reported here. It may be that some struvite stones developed in the presence of 
bacteriuria but no longer contain viable organisms.2,6,24 However, to the surgeon the 
environment in which a stone formed is less important than the existence of pathogens in a 
stone at the time of PCNL when the risk of infectious complications is highest.9,22
In this study we found that 32.7% of metabolic stone formers contained infectious organisms 
in their stones. Interestingly 12 (92.3%) of our patients with sepsis were metabolic stone 
formers. Despite the popular belief that patients with struvite stones carry a higher risk of 
severe infectious sequelae, our data suggest that it is the patient with recurrent metabolic 
stones whose stones often become secondarily infected with resistant organisms after 
repeated instrumentation and multiple courses of antibiotics who is at higher risk for sepsis 
after PCNL.
Finally, the process of obtaining a stone culture at PCNL is easy and usually requires less 
than 1 minute of additional operative time. The cost of a stone culture is minimal compared 
to the cost of a single septic event. We encourage all urologists to incorporate stone culture 
at PCNL into routine practice.
CONCLUSIONS
Obtaining an intraoperative stone culture is an easy, inexpensive and valuable practice that 
should be a routine part of any percutaneous stone removal procedure. The rate of 
discordance between urine and stone cultures in this study was 23%, consistent with the 
results of previous smaller studies and strengthened by this large cohort of patients. Gram-
positive organisms are considerably more common in the current era of patients requiring 
PCNL.
Abbreviations and Acronyms
CT computerized tomography
PCNL percutaneous nephrolithotomy
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SIRS systemic inflammatory response syndrome
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Figure. 
Types of organisms identified in preoperative urine culture (A) and intraoperative stone 
culture (B). Numbers in parentheses represent number of patients.
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Table 1
Patient and stone demographics
Mean pt age (range) 53.2 (3–90)
No. gender (%):
  M 358 (46.1)
  F 418 (53.9)
Unilat stones:
  No. pts 590
  No. rt side 252
  No. lt side 338
  No. size greater than 2 cm (%) 476 (61.3)
  No. size less than 2 cm (%) 107 (13.8)
  No. size not recorded 2
Bilat stones:
  No. pts 186
  No. size greater than 2 cm (%) 162 (20.9)
  No. size less than 2 cm (%) 22 (2.8)
  No. size not recorded 7
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Table 2
Preoperative bladder urine culture as a predictor of intraoperative stone culture results
Any Pos
Stone Culture
Same Organism
Found in Urine
Sensitivity for predicting stone culture results 0.75 0.62
Specificity for predicting stone culture results 0.73 0.60
Pos predictive value of urine culture 0.64 0.35
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Table 3
Operative data comparing patients who did or did not experience sepsis
Sepsis No Sepsis
Mean mins surgery time (range) 162 (64–313)* 128 (28–400)
Mean tracts (range) 2.0 (1–5) 1.39 (1–7)
No./total No. pos blood cultures 4/11† Not applicable
*Surgery time not available for 3 patients.
†
Blood cultures not done in 2 patients.
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Table 4
Urine and stone cultures with respect to stone composition
No. Struvite/Highly
Carbonated Apatite Stone (%)
No. Metabolic
Stone (%)
Both cultures neg 15 (12) 330 (51.2)
Pos urine culture only 23 (18.4) 104 (16.1)
Pos stone culture only 11 (8.8) 63 (9.8)
Both cultures pos 76 (60.8) 148 (22.9)
  Totals 125 645
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